L Grinberg. Show Affiliations »
Abstract
Mesh： See more » Anti-HIV Agents/economicsAntiviral Agents/economicsBenzoxazinesDideoxynucleosides/economicsDrug PackagingDrug Therapy, CombinationHIV Infections/drug therapyHIV Protease Inhibitors/economicsHepatitis C/drug therapyHumansInterferon alpha-2Interferon-alpha/economicsOxazines/economicsRecombinant ProteinsReverse Transcriptase Inhibitors/economicsRibavirin/economicsUnited States
Substances： See more » Anti-HIV AgentsAntiviral AgentsBenzoxazinesDideoxynucleosidesHIV Protease InhibitorsInterferon alpha-2Interferon-alphaOxazinesRecombinant ProteinsReverse Transcriptase InhibitorsRibavirinefavirenzabacavir
Year: 1998 PMID： 11366020
Source DB: PubMed Journal: GMHC Treat Issues ISSN： 1077-1824